Pharma Journalist -

STORM Therapeutics, the biotechnology company focused on the discovery of small molecule therapies targeting RNA epigenetic mechanisms, announces that it has been awarded a Biomedical…
Read More...

Genesis Therapeutics, a company pioneering artificial intelligence technologies to create medicines for patients with severe and unmet medical conditions, announced that it has entered…
Read More...

Nicoya Lifesciences, a global innovator of digital proteomics solutions for diagnostics and biotherapeutic discovery, announced the acquisition of LSK Technologies, a University of…
Read More...

Endo International plc announced that its subsidiary Endo Ventures Limited (EVL) acquired six development-stage, ready-to-use injectable product candidates from Nevakar Injectables…
Read More...

Horizon Therapeutics plc announced the European Commission (EC) approval of UPLIZNA (inebilizumab) as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum…
Read More...

Supernus Pharmaceuticals, Inc. a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced that…
Read More...

Intravacc B.V., a world leader in translational research and development of preventive and therapeutic vaccines, announced the signing of an exclusive licensing agreement with Beijing…
Read More...

Inmagene Biopharmaceuticals announces that the U.S. Food and Drug Administration (FDA) has cleared drug candidate IMG-007, a monoclonal antibody against OX40, to proceed to Phase I…
Read More...

AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved RINVOQ (upadacitinib; 15 mg, once daily) for the treatment of adults with active ankylosing spondylitis…
Read More...

GC Biopharma and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics, announced that they…
Read More...